In clear cell renal cell carcinoma (ccRCC), TLSs correlate with improved survival and enhanced immunotherapy responses, although elevated <i>CXCL13</i> expression may paradoxically signal more aggressive disease. This evidence concerns the gene CXCL13 and nonpapillary renal cell carcinoma.